✦ LIBER ✦

Safety and efficacy of teneligliptin: a novel DPP-4 inhibitor for hemodialysis patients with type 2 diabetes

✍ Scribed by Otsuki, Hideo; Kosaka, Takeo; Nakamura, Kenzo; Shimomura, Fumihiko; Kuwahara, Yoshitaka; Tsukamoto, Takuji

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety and dose-response relat

✍ Kadowaki, T.; Kondo, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

PDB3 EFFICACY AND SAFETY OF DIPEPTIDYL-P

✍ H Park; YA Kim; KL Rascati 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PDB10 A Meta-Analysis of Efficacy and Sa

✍ H. Park; C. Park; Y. Kim; K.L. Rascati 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Efficacy and Tolerability of the DPP-4 I

✍ DeFronzo, R. A.; Burant, C. F.; Fleck, P.; Wilson, C.; Mekki, Q.; Pratley, R. E. 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 427 KB

Discovery of Imigliptin, a Novel Selecti

✍ Shu, Chutian; Ge, Hu; Song, Michael; Chen, Jyun-hong; Zhou, Huimin; Qi, Qu; Wang 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 786 KB

Sitagliptin, a DPP-4 inhibitor for the t

✍ Karasik, Avraham; Aschner, Pablo; Katzeff, Harvey; Davies, Michael J.; Stein, Pe 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 462 KB